Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXN3PH
|
||||
Drug Name |
4-{5-[(2-Cyclohexylmethyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino)-methyl]-imidazol-1-ylmethyl}-benzonitrile
|
||||
Synonyms |
CHEMBL348850
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H33N5O
|
||||
Canonical SMILES |
O=C1C(Cc2ccccc2CN1CC3CCCCC3)NCc4cncn4Cc5ccc(cc5)C#N
|
||||
InChI |
InChI=1S/C29H33N5O/c30-15-22-10-12-24(13-11-22)19-34-21-31-16-27(34)17-32-28-14-25-8-4-5-9-26(25)20-33(29(28)35)18-23-6-2-1-3-7-23/h4-5,8-13,16,21,23,28,32H,1-3,6-7,14,17-20H2
|
||||
InChIKey |
GERFWDRHAJVQRY-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.